Study to Evaluate CCS1477 in Advanced Tumours
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- 120
Summary
- Conditions
- Advanced Solid Tumors
- Metastatic Castration Resistant Prostate Cancer
- Type
- Interventional
- Phase
- Phase 1Phase 2
- Design
- Allocation: Non-RandomizedIntervention Model: Sequential AssignmentIntervention Model Description: The RP2D/MTD dose will be determined in Part A. Parts B-E will run in parallel after the completion of Part A.Masking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03568656
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Johann de Bono, MD Royal Marsden NHS Foundation Trust
Get Well Soon